Loading organizations...
Loading organizations...
Drug development for Alzheimer's and neurodegenerative diseases.
Galantos Pharma has raised $5.7M across 1 funding round.
Galantos Pharma has raised $5.7M in total across 1 funding round.
Galantos Pharma has raised $5.7M in total across 1 funding round.
Galantos Pharma's investors include Federal Ministry of Education and Research, FIB, High-Tech Grunderfonds, KfW, VRP, WFT.
Galantos Pharma has raised $5.7M across 1 funding round. Most recently, it raised $5.7M Series C in May 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 4, 2010 | $5.7M Series C | Federal Ministry of Education and Research, FIB, High-Tech Grunderfonds, KfW, VRP, WFT |